Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Parkinson Disease Frontal Cortex Transcriptomic analysis

ABSTRACT: Parkinson Disease Frontal Cortex Transcriptomic analysis

PROVIDER: PRJNA659523 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12523000_1.fastq.gz	Fastqsanger.gz
	SRR12523000_2.fastq.gz	Fastqsanger.gz
	SRR12523001_1.fastq.gz	Fastqsanger.gz
	SRR12523001_2.fastq.gz	Fastqsanger.gz
	SRR12523002_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 30

Similar Datasets

Parkinson Disease Frontal Cortex ncRNA Profiling

Project description:Parkinson Disease Frontal Cortex ncRNA Profiling

| PRJNA659521 | ENA

Parkinson Disease Frontal Cortex Transcriptomic analysis

Project description:We analyzed the transcriptome of the Frontal Cortex (FC) of Parkinson diseased (PD) individuals compared to age-matched controls.

2024-09-03 | GSE156928 | GEO

Parkinson Disease Frontal Cortex ncRNA Profiling

Project description:We aimed to profile the expression of the entire population of annotated lncRNAs (GENCODE 15) in the Frontal Cortex (FC) of Parkinson diseased (PD) individuals compared to age-matched controls.

2024-09-03 | GSE156926 | GEO

Microarrays of frontal cortex (area 8) of Parkinson cases and controls

Project description:Microarrays of frontal cortex (area 8) of Parkinson cases and controls

2013-06-02 | E-MTAB-1194 | biostudies-arrayexpress

Whole genome expression in Parkinson disease and neurologically healthy control prefrontal cortex Brodmann area 9 samples

Project description:Whole genome expression in Parkinson disease and neurologically healthy control prefrontal cortex Brodmann area 9 samples

2012-09-19 | E-MTAB-812 | biostudies-arrayexpress

Affymetrix 6.0 study of sporadic motor neuron disease patients and controls.

Project description:This data was divided into three experiment sets: 1. A somatic study of sporadic motor neuron disease (SMND) brain samples that were compared to the blood from the same individual, normal control brains and disease control brans (Parkinson Disease patients); 2. A twin study comparing blood and other tissue samples from twins that were discordant for MND, concordant for MND and control twins and 3. A trio study of blood samples MND patients compared to their unaffected parents. Study 1: 36 sporadic motor neuron disease brain (lateral frontal cortex, Brodmann area 46), 34 matched sporadic motor neuron disease blood, 26 control brain (lateral frontal cortex, Brodmann area 46), 9 Parkinson Disease brain (disease controls, lateral frontal cortex, Brodmann area 46). Study 2 and study 3: 52 twin or trio blood, 4 twin hair, 1 twin sperm. 2 replicate twin blood and 1 replicate trio blood repeated at a different time. External control blood from Coriell GM15510 and GM10851.

2010-07-31 | E-GEOD-15826 | biostudies-arrayexpress

Transcriptome Alterations in Myotonic Dystrophy Frontal Cortex

Project description:Transcriptome Alterations in Myotonic Dystrophy Frontal Cortex

| PRJNA661286 | ENA

RNA-seq of frontal cortex in a novel mouse model of Alzheimer's disease.

Project description:RNA-seq of frontal cortex in a novel mouse model of Alzheimer's disease.

| PRJEB32132 | ENA

Co-expression network analysis of frontal cortex during the progression of Alzheimer’s disease

Project description:Co-expression network analysis of frontal cortex during the progression of Alzheimer’s disease

| PRJNA771353 | ENA

Frontal Cortex whole transcriptome sequencing in COVID-19 elderly patients

Project description:SARS-Cov-2 infection is frequently associated with Nervous System (NS) manifestations. However, it is not clear how SARS-CoV-2 can cause neurological dysfunctions and which molecular processes affects. In this work, we examined the frontal cortex tissue of patients who died of COVID-19 for the presence of SARS-CoV-2, comparing qRT-PCR with ddPCR. We also investigated the transcriptomic profile of frontal cortex from COVID-19 patients and matched controls by RNA-seq analysis to characterize the transcriptional signature.

2021-03-09 | GSE164332 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data